Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver (NCT03472586)
Organization linked by public source evidence.
No public external ID is attached.
No reviewed person affiliation is attached.
No reviewed output is linked through affiliated people.
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver (NCT03472586)
No dated relationship evidence is attached.